tm logo
KRRO-110
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 12 Nov 2024

Last Applicant/ Owned by

Suite 6-401

Cambridge

MA

02139

Serial Number

98365999 filed on 19th Jan 2024

Registration Number

N/A

Correspondent Address

Tiffany D. Gehrke

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP

Suite 6300

Chicago, IL 60606

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KRRO-110

Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development Oligonucleotide preparations for the treatment of genetic diseases

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Oligonucleotide preparations for the treatment of genetic diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98365999

Mark Type

No Service Mark

Attorney Docket Number

No 33791/60007

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
12th Nov 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Sep 2024PUBLISHED FOR OPPOSITION
28th Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15th Aug 2024ASSIGNED TO EXAMINER
15th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
26th Jul 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19th Jan 2024NEW APPLICATION ENTERED